Pages

Thursday, October 17, 2013

(LML) MB patients without clear treatment status and chronic ENL

Leprosy Mailing List – October 17,  2013 

Ref.:    (LML) MB patients without clear treatment status and chronic ENL

From:  José Augusto, Rio de Janeiro, Brazil


Dear Pieter,

We received some MB patients from other states without reliable information about their treatment history and if they received  the full course of MDT. Most of these patients have still a high BI. These patients have maintained reactional episodes of ENL which are difficult to control.

Do you think these patients should be restated MDT to ensure a full course of MDT while we are trying to reduce these episodes of type II reaction? As reaction treatment usually  thalidomide is given together with or without prednisone and pentoxifylline.

What is the advice of LML readers regarding this same situation (to restart a full course of MDT or not) in other countries?

 

Best regards,

 


Dr. José Augusto da Costa Nery

Ambulatório Souza Araújo

Laboratório de Hanseníase

Instituto Oswaldo Cruz - Fiocruz

Av. Brasil 4365, Manguinhos, Rio de Janeiro - RJ CEP 21040-360

Tel. (21)2562-1588

neryjac@ioc.fiocruz.br

 


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.